Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do no harm--normal tissue effects.

E J Hall1

  • 1Center for Radiological Research, Columbia University, College of Physicians & Surgeons, New York 10032, USA. ejhl@columbia.edu

Acta Oncologica (Stockholm, Sweden)
|February 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of GS-441524 following intravenous remdesivir in six cats and results of therapeutic drug monitoring during treatment of feline infectious peritonitis: 22 cases (2021-2024).

The Journal of small animal practice·2025
Same author

Whole-Blood Taurine Concentrations in Cats With Intestinal Disease.

Journal of veterinary internal medicine·2017
Same author

Comparison of 3 Handling Techniques for Endoscopically Obtained Gastric and Duodenal Biopsy Specimens: A Prospective Study in Dogs and Cats.

Journal of veterinary internal medicine·2016
Same author

Campylobacter Species and Neutrophilic Inflammatory Bowel Disease in Cats.

Journal of veterinary internal medicine·2016
Same author

Bacterial Cholangitis, Cholecystitis, or both in Dogs.

Journal of veterinary internal medicine·2016
Same author

Does the Murphy's eye perform its role?

Anaesthesia·2015
Same journal

Overall survival following palliative immune checkpoint inhibitor treatment according to ECOG performance status: a large registry-based study.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Pathological characteristics and prognosis of very young patients with early breast cancer: a comparative analysis with older patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Recent survival trends in the most fatal cancers in the Nordic countries: gains in some but not in all.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

First-in-human quantitative [¹⁵O]H₂O PET imaging of tumour blood flow at rest and during exercise in lymphoma patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Starshot field configuration in the linac isocentre size determination: a comparison of film and electronic portal imaging device measurements.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Perspectives on artificial intelligence-generated chronic disease risk predictions in early breast cancer: an international survey among radiation oncologists.

Acta oncologica (Stockholm, Sweden)·2026
See all related articles

Genetic predisposition may explain severe radiation therapy complications. Identifying radiosensitive patients genetically could prevent long-term harm and radiation-induced cancers.

Area of Science:

  • Oncology
  • Genetics
  • Radiology

Background:

  • Radiation therapy offers significant benefits but carries risks of late toxicity and secondary cancers.
  • A subset of patients experiences severe late complications, prompting investigation into their cause.

Purpose of the Study:

  • To determine if severe late radiation sequelae are random or linked to genetic predisposition.
  • To explore the potential for prospective genetic identification of radiosensitive patients.

Main Methods:

  • Review of experimental data from knockout mice.
  • Analysis of patient data to identify genetic factors associated with radiosensitivity.
  • Examination of large studies on radiation-induced malignancies.

Main Results:

Keywords:
NASA Discipline Radiation HealthNon-NASA Center

Related Experiment Videos

  • Evidence suggests individuals heterozygous for certain genes exhibit radiosensitivity.
  • Large studies confirm a statistically significant increase in radiation-induced malignancies post-radiotherapy.
  • Second cancers include carcinomas (often remote) and radiation-induced sarcomas (in irradiated areas).

Conclusions:

  • Genetic predisposition plays a role in severe late radiation therapy complications.
  • Prospective genetic screening could identify radiosensitive individuals, allowing for tailored treatment to mitigate risks.
  • Understanding genetic factors is crucial for balancing radiation therapy benefits against potential harms.